DBVT Breaks Out After Peanut Allergy Patch Update

Stifel upgraded DBVT to "buy" in response

by Patrick Martin

Published on Jan 9, 2020 at 9:43 AM

One of the better stocks on the Nasdaq this morning is DBV Technologies (NASDAQ:DBVT), up 16.6% to trade at $13.11. The French pharmaceutical company's peanut allergy patch Viaskin showed durable benefits in a study, prompting Stifel to raise its rating to "buy" from "hold."

While also upping its price target to $18 from $10, the analyst in coverage expects an independent panel vote or an approval later in 2020. Leerink also chimed in and noted Viaskin is a " safer and more patient friendly therapeutic alternative" than rival Aimmune Therapeutics' Palforzia treatment. Most of the analyst community is already bullish, with six out of nine giving out "buy" ratings, and the consensus 12-month price target sitting at $16.22, a 44.3% premium to last night's closing perch of $11.24.

DBVT stock is on track to post its best single-session gain since February 2018, and is currently trading at its highest point since a late-December 2018 bear gap. Late last month, the shares sliced through their 320-day moving average, and are now up 64% year-over-year. Plus, the biotech stock has turned in only six negative sessions since Dec. 2. 

If there's a word of caution to be said though, it's the stock's 14-day Relative Index (RSI). At the close last night, the equity's RSI settled firmly in overbought territory at 73, suggesting a caution should be exercised in the short term.


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Nevada Discovery That Could Jeopardize Chinese Dominance
Click to continue to advertiser's site.
Stocks Surge During Holiday-Shortened Week
Stocks chugged higher as the government responded to the coronavirus crisis with more funding
Bank Stocks Ease Investors Back Into Earnings Season
Bank stocks will kick off earnings season next week
The Top Lithium Play of 2020
Click to continue to advertiser's site.